|
We believe that the report completed by Professor Allars, her executive summaries and Dr Lawrence's speech to the House prove beyond any question that there had been significant breaches of the law as it applies to a wide variety of areas. These include the manufacture of the hormone, including the collection of glands, distribution of the hormone by various agencies, including HPAC, CSL and others as detailed in the Allars report, and non-disclosure of possible side effects
Raised Cancer Risk From Human Growth Hormone Treatment Lancet 07/25/2002 By Harvey McConnell An increase in cancer incidence compared with the general population has been found among British men and women given human pituitary growth hormone up to the mid 1980s. Dr. Anthony Swerdlow and colleagues at the Institute of Cancer Research, and Institute of Child Health, Sutton, Surrey, England, caution that the cases they found are small in number and there is no indication that growth hormone in modern dosage regimens is associated with an increased risk. At the same time, they declare: Our data do not show conclusively whether cancer incidence is increased by growth hormone treatment, but they do suggest the need for increased awareness of the possibility of cancer risks, and for surveillance of growth hormone-treated patients. Human pituitary growth hormone was first used to counteract short stature in children and young adults, but the advent of synthetic growth hormone has replaced human growth hormone therapy. The role of growth hormone in carcinogenesis is not clear, the researchers point out, but it raises serum concentrations of insulin-like growth factor (IGF)-I, which is mitogenic and antiapoptotic. Both in-vitro and animal studies suggest that growth hormone might raise the risk of hyperplasia and malignancy. Dr. Swerdlow and colleagues investigated cancer incidence and death in 1,848 British men and women who were treated during childhood and early adulthood with human pituitary growth hormone between 1959 and 1985. The risk of cancer in the study population was compared with that in the general population, controlling for age and sex. Although the overall number of patients who developed cancer was small (10 cases), it represented a significantly higher risk of mortality from cancer according to standardized mortality ratios. After the exclusion of patients whose reason for growth hormone treatment rendered them at a high risk of cancer, the risk of incidence of colorectal cancer was significant, as were the risks of death from colorectal cancer or Hodgkin's disease. Concern about cancer in patients treated with growth hormone has focused primarily on risk of leukemia, but no leukemia cases occurred after treatment among the cohort. Our finding adds to evidence from other cohort studies which suggest that leukemia risk is not substantially raised if high-risk groups such as those with chromosomal fragility are excluded. Dr Swerdlow and colleagues said there has been much less research on other cancer risks, and their findings are not reassuring. Despite the limitations in their study the high incidence of cancer, and in particular of colon cancer, is worrying. Frequency of colon cancer mortality after growth hormone treatment was raised. The number of cases was small, but is of concern because it concurs with raised risks found in patients with acromegaly and in individuals with previously increased concentrations of IGF-I. Because of the large relative risk and supporting evidence, there is an urgent need to obtain further data, they conclude Lancet 2002; 360: 273-77. |
|
What about other diseases? Adrenal Crisis, Attention Deficit Hyperactivity Disorder.(ADHD) Many people treated with hGH also have problems with other pituitary hormones. A pituitary hormone tells the adrenal gland to make cortisol, a hormone needed for life. People lacking this hormone are at risk of death from adrenal crisis, but this can be prevented. More hGH recipients have died from adrenal crisis than from CJD. Please read the enclosed yellow sheet and discuss the information with your doctor.
Adrenal crisis is a preventable cause of death in people who have been treated with hGH. Many of these people do not know about their risk of adrenal crisis, though it has caused more deaths than CJD.
Most people who received hGH lack growth hormone. They may also lack other key hormones made by the pituitary gland. Having too little of these hormones can be fatal if not properly treated. Earlier updates have talked about how adrenal crisis can be prevented, but deaths have still occurred.
Melanoma, Basel Cell Carcinoma and Melanocytic Naevi The authors conclude that the increased rate of growth of melanocytic nevi and the presence of HMB-45 staining within dermal nevus cells suggest that HGH may have a stimulatory effect on melanocytes
If there is a severe shortage of cortisol then an individual’s life can be in danger with an adrenal crisis. This event is very rare is will never happen to most people with CAH who take treatment regularly, make appropriate increases in dose when ill and seek help early if unexpectedly unwell or vomiting. The symptoms are faintness, nausea, vomiting and abdominal pain. An adrenal crisis can be triggered by a stressful illness such as severe flu or gastro-enteritis. An injection of hydrocortisone should be given immediately. Admission to hospital may be needed so that fluids can be given into a vein – a ‘saline drip’. If in doubt – always give an injection of hydrocortisone and go to the nearest accident and emergency department.
Background: Do not confuse acute adrenal crisis with Addison disease. In 1855, Thomas Addison described a syndrome of long-term adrenal insufficiency, which develops over months to years, with weakness, fatigue, anorexia, weight loss, and hyperpigmentation as the primary symptoms. In contrast, an acute adrenal crisis can present with vomiting, abdominal pain, and hypovolemic shock
The symptoms are faintness, nausea, vomiting, abdominal pain and dehydration. Make sure you always wear your Medical Alert bracelet which is available through the link at Chemists for around $45
Issues for Men with CAH
--------------------------------------------------------------------------------
The problems of weight gain and the side effects of treatment can affect men as much as women. Short stature, which can result for difficulties in treatment of CAH in childhood, can be a particular psychological burden for men. High levels of testosterone in CAH can cause problems with aggression and excessive sex drive in men.
There are two important long-term consequences of CAH which only affect men, both of which are the result of too little treatment with cortisol. These are infertility and testicular enlargement. If adrenal suppression is inadequate then the adrenal gland makes too much testosterone. High testosterone production from the adrenal gland can occur because the dose of cortisol is too low or because tablets have been missed. The testicles, which also make testosterone, then shutdown as the testosterone levels are high. Unfortunately, 'shutting down' the testicles also means that sperm are not produced in normal quantities and this can cause infertility. Sperm production usually picks up if the adrenal cortisol treatment is increased allowing the testosterone production from the adrenal glands to fall, so the testicles can begin to work again. It can take several months the sperm count to rise after an increase in steroid treatment.
Testicular enlargement is a rare effect of under dosage of cortisol treatment and it takes many years of inadequate treatment for this to occur. Normal testicles contain a few adrenal cells that enlarge if the levels of cortisol in the body are low. This enlargement usually goes away if the dose of cortisol treatment is increased. Occasionally doctors advise a biopsy of the enlarged testicle to make sure that there is no hidden cancer. CAH does not cause cancer but it is reassuring to make this check.
Growth Hormone in Non-GH-Deficient Short Stature: Open Questions Support Long-Term Follow-up In Australia, more stringent entry and exit criteria for use of GH were introduced in 1993-1994. According to Dr. Werther's article in the May issue of the Journal of Pediatric Endocrinology and Metabolism, patient numbers and drug costs were halved after the guidelines were implemented. Of 1,250 Australian children currently being treated with GH, 26% have idiopathic short stature, with final adult height -1.8 standard deviation score (SDS), or improvement of 1.1 SDS.
How steroids work
Steroids work by imitating the properties of naturally occurring hormones. Muscle tissue is peppered with receptor sites specific to growth. These sites or 'locks' can only be accessed by the correct hormonal 'key'. Steroids can activate these receptor sites because their chemical composition is so similar to the hormone testosterone. Once the receptor sites have been stimulated, a domino effect of metabolic reactions takes place as the body is instructed by the drug to increase muscle tissue production.
SEX STEROIDS AND SEXUAL DIFFERENTIATION, the side effects of Steroids on the Male brain Males are more likely to present with conduct disorders, attention-deficit/hyperactivity disorder (ADHD), substance abuse, learning disorders, and chronic motor tics. Furthermore, the onset of male-typed disorders and other psychiatric disorders, such as schizophrenia and OCD
Adrenal crisis is a preventable cause of death in people who have been treated with hGH Adrenal crisis is a preventable cause of death in people who have been treated with hGH. Many of these people do not know about their risk of adrenal crisis, though it has caused more deaths than CJD.
|
![]() |
This Webpage has been created using the my connected community (mc2) Webpage generator. my connected community (mc2) is funded by the Victorian Government and coordinated by VICNET |